Alterations of Tear Mediators in Patients with Keratoconus after Corneal Crosslinking Associate with Corneal Changes

被引:33
|
作者
Kolozsvari, Bence Lajos [1 ]
Berta, Andras [1 ]
Petrovski, Goran [2 ,3 ]
Mihaltz, Kata [4 ]
Gogolak, Peter [5 ]
Rajnavoelgyi, Eva [5 ]
Hassan, Ziad [1 ]
Szeles, Peter [1 ]
Fodor, Mariann [1 ]
机构
[1] Univ Debrecen, Dept Ophthalmol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Stem Cells & Eye Res Lab, Dept Biochem & Mol Biol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
[3] Univ Szeged, Dept Ophthalmol, Fac Med, Szeged, Hungary
[4] Hietzing Hosp, Dept Ophthalmol, Vienna, Austria
[5] Univ Debrecen, Dept Immunol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
来源
PLOS ONE | 2013年 / 8卷 / 10期
关键词
NERVE GROWTH-FACTOR; PROGRESSIVE KERATOCONUS; INFLAMMATORY MOLECULES; ULTRAVIOLET-A; MATRIX-METALLOPROTEINASES; COLLAGEN; RIBOFLAVIN; ECTASIA; DEGRADATION; EXPRESSION;
D O I
10.1371/journal.pone.0076333
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Keratoconus (KC) is the most common primary corneal ectatic disease which has considerable importance in public health. Corneal collagen crosslinking (CXL) is a procedure to mitigate progression of KC and reduce demand for corneal transplantation. Although studies have proven the efficacy of CXL regarding corneal shape, none have investigated the effects of CXL on tear biomarkers which are useful tools to understand molecular mechanisms behind CXL. Our purpose was to determine the effect of CXL on tear mediators in patients with KC and analyze associations with corneal changes. Tear samples were collected pre-CXL from 26 eyes of 23 patients and during a 12-month follow-up. The mediators' concentration was measured by Cytometric Bead Array technology. Corneal topography parameters measured by Scheimpflug Camera included: Thinnest-corneal-thickness (ThCT), keratometry values (K1, K2), Radii-Minimum (Rmin), Keratoconus-Index (KI), Center-KI (CKI), Index-of-Height Asymmetry (IHA) and Index-of-Surface Variance (ISV). At baseline, KI was correlated negatively with chemokine (C-C motif) ligand 5 (CCL5) (p=0.015) and matrix metalloproteinase (MMP)-13 (p=0.007). At day 4, interleukin (IL)-6 and IL-8 increased, while IL-13, IL-17A, interferon (IFN)-gamma, CCL5, MMP-13, epidermal growth factor (EGF), nerve growth factor (NGF) and plasminogen activator inhibitor (PAI-1) decreased significantly compared to pre-CXL concentrations (p=0.02). At 6 months tissue plasminogen activator (t-PA) increased (p=0.02), while at 12 months Rmin increased (p=0.004), and IL-6 and CXCL8 (p=0.005 and p=0.047) as well as K1, ISV and KI decreased. After 6 months CKI and ISV showed significant associations with IL-17A; CKI with IL-13 and ThCT with IL-13 (p=0.02), while at 12 months there were reverse associations between ThCT and IL-6, IL-13, INF gamma, CCL5 and PAI-1 (p=0.02). Alterations of mediators in tear fluid after CXL associate with topographic changes highlight the fact that many mediators are involved in the complex mechanisms after CXL. Further studies on biomarkers to investigate the efficacy of CXL are needed.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Natural history of corneal haze after corneal collagen crosslinking in keratoconus using Scheimpflug analysis
    Kim, Bia Z.
    Jordan, Charlotte A.
    McGhee, Charles N. J.
    Patel, Dipika V.
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2016, 42 (07) : 1053 - 1059
  • [22] Effect of Corneal Collagen Cross-Linking on Corneal Innervation, Corneal Sensitivity, and Tear Function of Patients with Keratoconus
    Kontadakis, Georgios A.
    Kymionis, George D.
    Kankariya, Vardhaman P.
    Pallikaris, Aristophanis I.
    OPHTHALMOLOGY, 2013, 120 (05) : 917 - 922
  • [23] Accelerated corneal crosslinking for treatment of progressive keratoconus in pediatric patients
    Ulusoy, Dondu M.
    Goktas, Emre
    Duru, Necati
    Ozkose, Ayse
    Atas, Mustafa
    Yuvaci, Isa
    Arifoglu, Hasan B.
    Zararsiz, Gokmen
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (03) : 319 - 325
  • [24] Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement
    Wollensak, Gregor
    Iomdina, Elena
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2009, 35 (03) : 540 - 546
  • [25] Impact of keratoconus stage on outcome after corneal crosslinking
    Gassel, Caroline Julia
    Roeck, Daniel
    Konrad, Eva-Maria
    Blumenstock, Gunnar
    Bartz-Schmidt, Karl Ulrich
    Roeck, Tobias
    BMC OPHTHALMOLOGY, 2022, 22 (01)
  • [26] Transepithelial corneal collagen crosslinking for keratoconus: Six-month results
    Lesniak, Sebastian P.
    Hersh, Peter S.
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2014, 40 (12) : 1971 - 1979
  • [27] Corneal collagen crosslinking for keratoconus or corneal ectasia without epithelial debridement
    Hirji, N.
    Sykakis, E.
    Lam, F. C.
    Petrarca, R.
    Hamada, S.
    Lake, D.
    EYE, 2015, 29 (06) : 764 - 768
  • [28] Corneal Crosslinking for Keratoconus in Iranian Patients: Outcomes at 1 year following treatment
    Saffarian, Ladan
    Khakshoor, Hamid
    Zarei-Ghanavati, Mehran
    Esmaily, Habibollah
    MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY, 2010, 17 (04) : 365 - 368
  • [29] Severe microbial keratitis and associated perforation after corneal crosslinking for keratoconus
    Rana, M.
    Lau, A.
    Aralikatti, A.
    Shah, S.
    CONTACT LENS & ANTERIOR EYE, 2015, 38 (02) : 134 - 137
  • [30] Patient subjective visual function after corneal collagen crosslinking for keratoconus and corneal ectasia
    Brooks, Nneka O.
    Greenstein, Steven
    Fry, Kristen
    Hersh, Peter S.
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2012, 38 (04) : 615 - 619